Generate:Biomedicines, founded in 2018, is a biotechnology company and developer of a generative biology platform that seeks to use AI and machine learning to create pharmaceutical therapies on demand. Through its Generate Platform, the company aims to produce therapies for constantly changing clinical targets, with the goal of reducing the time and money required to respond to medical conditions. Generate:Biomedicines is headquartered in Somerville, Massachusetts.

Register for Details

For more details on financing and valuation for Generate Biomedicines, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Generate Biomedicines

Forge green plus iconForge green minus icon

What is Generate Biomedicines's IPO price?

The IPO price for Generate Biomedicines will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Generate Biomedicines?

Generate Biomedicines is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Generate Biomedicines shares pre-IPO?

If you own Generate Biomedicines pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Generate Biomedicines a publicly traded company?

Generate Biomedicines is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Generate Biomedicines's funding to date?

Generate Biomedicines has raised $686.67MM to date.
Forge green plus iconForge green minus icon

When was Generate Biomedicines founded?

Generate Biomedicines was founded in 2018.

Who are Generate Biomedicines's major investors?

Arch Venture Partners
Fidelity Management & Research
T. Rowe Price
Alaska Permanent Fund
Flagship Pioneering
Morningside Group
Amgen Ventures
Abu Dhabi Investment Authority
Altitude Life Science Ventures
Partners Investment
March Capital
Maps Capital
Pictet Alternative Advisors

Generate Biomedicines funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation

Series C

$273MM raised $XXX.XX $XXX.XX

Series B

$373.42MM raised $XXX.XX $XXX.XX

Series A

$40.25MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jun 15, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.